Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06960616 · ClinicalTrials.gov registry record · NA
Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy
A NA study of Deafness and Cochlear Hearing Loss, sponsored by Massachusetts Eye and Ear Infirmary.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT06960616: Recruiting NA study of Deafness and Cochlear Hearing Loss, sponsored by Massachusetts Eye and Ear Infirmary.
NCT06960616 is a NA study of Deafness and Cochlear Hearing Loss that is actively recruiting participants, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 48 participants, below the 613-participant average among 11 other Deafness trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06960616, a NA study of Deafness and Cochlear Hearing Loss, is actively recruiting participants, sponsored by Massachusetts Eye and Ear Infirmary.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is about the importance of each follow-up visit after activating a new cochlear implant in addition to evaluating the effectiveness and efficiency of a new programming strategy from Cochlear Americas. Investigators are looking for patients who have recently selected Cochlear Americas as their cochlear implant manufacturer of choice for their upcoming surgery. The aim of this study is to determine if 1) patient outcomes remain stable when reducing follow-up appointments and 2) Cochlear's population mean mapping can produce similar outcomes with patients while additionally reducing appointment times. The hypothesis is that using population mean mapping and reducing the number of follow-up visits after activation will yield similar performance outcomes to a standard of care while decreasing the length of appointment times and number of appointments needed for each patient.
Primary Outcome
Speech perception scores via CNC word lists (percentages) at each visit. Scores are from 0 to 100% with 100% being the best.
Conditions Studied
Interventions
- OTHER Changes in traditional follow-up
- OTHER Population mean mapping
Study Locations (1)
Massachusetts
- Mass Eye and Ear - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2024-02-27 |
| Est. Completion | 2026-02-26 |
| Phase | NA |
What NCT06960616 shows while recruiting
NCT06960616 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 613-participant average among 11 other Deafness trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Deafness appearing as the primary indexed condition, and to 2 interventions - of which Changes in traditional follow-up is the first listed.
NCT06960616 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06960616 about?
NCT06960616 is a clinical study titled "Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy". The study is about the importance of each follow-up visit after activating a new cochlear implant in addition to evaluating the effectiveness and efficiency of a new programming strategy from Cochlear Americas. Investigators are looking for patients who have recently selected Cochlear Americas as th...
What is the current status of trial NCT06960616?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2024-02-27. Estimated completion is 2026-02-26.
What conditions does trial NCT06960616 study?
This clinical trial studies the following conditions: Deafness, Cochlear Hearing Loss.
What interventions are being tested in trial NCT06960616?
The interventions under investigation include: Changes in traditional follow-up (OTHER), Population mean mapping (OTHER).
Who is sponsoring clinical trial NCT06960616?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06960616 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Deafness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06960616's enrollment target sits among peer trials
48 8th of 11 higher than 4 of 11 other Deafness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Deafness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants
RECRUITING · NA
-
Novel Coding Strategies for Children With Cochlear Implants
RECRUITING · NA
-
Word Learning in Deaf Children Using Eye-tracking and Behavioral Measures
RECRUITING · NA
-
Hearing Program in Primary Care
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI